Evercore ISI Group Maintains In-Line on GoodRx Holdings, Raises Price Target to $10
Portfolio Pulse from jenniferd'souza@benzinga.com
Evercore ISI Group analyst Mark Mahaney maintains an In-Line rating on GoodRx Holdings (NASDAQ:GDRX) and raises the price target from $7 to $10.
August 10, 2023 | 1:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group maintains an In-Line rating on GoodRx Holdings and raises the price target from $7 to $10.
The raised price target by Evercore ISI Group indicates a positive outlook for GoodRx Holdings. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100